who can take glp 1 GLP-1 drugs are trending… but so are the myths. ❌ “It's just a fad.” ❌ “You lose weight instantly.” ❌ “Anyone it.” ✓ Reality: These medications work through well-studied metabolic research2guidance - GLP-1 Market: The

During that time period, prescriptions for drugs like Ozempic and Wegovy (semaglutide) increased from about 0.8 million to more than 1.5 million, growing annually at a rate of 5.3%

There is no large human trial of the combo, so stack before and after reports are anecdotal, not proven

Such expansion addresses immediate supply issues and prepares the company to handle future demand surges better, whether for existing products like Ozempic and Wegovy or for upcoming treatments like Eli Lillys Mounjaro

Researchers are starting to get a closer view of the various gray-market peptides making the rounds on the back of the looksmaxxing trend, and it isnt looking good